When does Global Bioenergies report earnings and why does it matter for ALGBE.PA stock?

Global Bioenergies reports on **2026-02-02**. The update matters because investors expect clarity on revenue recognition, commercial contracts, and cash runway, all of which directly affect ALGBE.PA stock volatility and short-term valuation

What is Meyka AI’s grade for ALGBE.PA and what does it imply for investors?

Meyka AI rates ALGBE.PA **68.53 (Grade B, HOLD)**. The grade reflects mixed fundamentals, sector comparison and forecast inputs. It suggests monitoring earnings outcomes rather than initiating large positions

How does Meyka AI’s forecast compare to the current ALGBE.PA stock price?

Meyka AI's forecast model projects **€0.49** versus the current **€0.0185**, implying **2,548.65%** upside. Forecasts are model-based projections and not guarantees

What are the biggest risks to ALGBE.PA stock in the earnings report?

Major risks include missed commercial milestones, further capital raises, negative operating cash flow, and lack of near-term revenue visibility. Any sign of increased dilution would pressure ALGBE.PA stock

EU Stocks

Pre-market: ALGBE.PA Global Bioenergies EURONEXT €0.0185 pre-Feb2 earnings: runway

ByHuzaifa Zahoor January 28, 2026

ALGBE.PA stock trades at €0.0185 in pre-market Europe trading as investors brace for Global Bioenergies SA’s earnings on 2 Feb 2026. With a market cap of €335,375.00 and 50-day average €0.02, the small-cap utilities issuer faces scrutiny on cash runway, contract progress and revenue recognition. Ahead of the report, trading volume of 32,615 shares and a shallow order book increase the chance of outsized moves. We highlight the ratios, liquidity, and the key metrics analysts will watch in the Feb 2 release